Skip to main content
UniHealth

Doctor search

Maynard Lam, PHARMD

Pharmacist · Sunnyvale

NPI 1982066684

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Maynard Lam’s office at (408) 530-2806 to ask if they take your plan before you enroll.

California Medical Board record

Licence G75271 · Cancelled

Licence status: Cancelled · since 1992 · University of Kansas School of Medicine.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$167,399

Pharmacies billed $167,399 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 838) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.

459 generic and 301 brand-name prescriptions · $167,399 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic96$71,076$740
Humulin R U-500 Kwikpen12$31,690$2,641
Jardiance29$16,263$561
Victoza 2-Pak14$8,941$639
Insulin Glargine-Yfgn46$7,024$153
See all 23 drugs
Every Part D drug this clinician prescribed
Ozempic96$71,076$740
Humulin R U-500 Kwikpen12$31,690$2,641
Jardiance29$16,263$561
Victoza 2-Pak14$8,941$639
Insulin Glargine-Yfgn46$7,024$153
Humulin N28$4,237$151
Humulin N Kwikpen18$3,177$176
Humulin R22$2,811$128
Glipizide82$1,169$14
Atorvastatin89$1,117$13
Metformin Hcl Er93$915$10
Metformin62$862$14
Ultra-Fine Nano Pen Needle22$637$29
Glipizide Er18$557$31
Ultra-Fine Mini Pen Needle14$295$21
Veo Insulin13$255$20
Losartan20$247$12
Veo Insulin14$233$17
Pioglitazone18$216$12
Lisinopril15$175$12
Simvastatin11$128$12
Rosuvastatin11$128$12
Amlodipine Besylate11$128$12

Year by year

Part D prescribing by year
20248382090% (0)36%$167,399
20236992130% (0)34%$128,435
20228231890% (0)31%$116,065
20218101950% (0)37%$103,998
20207872110% (0)31%$77,177
20195451780% (0)24%$44,109
2018114510% (0)47%$27,046

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 18 drugs

Part D drugs prescribed in 2023
Ozempic44$46,027$1,046
Jardiance31$22,040$711
Humulin N Kwikpen35$7,301$209
Humulin N44$6,351$144
Humalog12$2,839$237
Humulin R15$1,914$128
Glipizide90$1,307$15
Atorvastatin78$1,218$16
Metformin50$708$14
Metformin Hcl Er57$597$10
Ultra-Fine Nano Pen Needle22$422$19
Veo Insulin19$375$20
Glipizide Er12$371$31
Ultra-Fine Mini Pen Needle15$352$23
Veo Insulin14$313$22
Pioglitazone13$252$19
Lisinopril15$182$12
Losartan13$152$12

2022: 16 drugs

Part D drugs prescribed in 2022
Jardiance20$15,893$795
Humulin N72$13,646$190
Lantus24$10,272$428
Humulin N Kwikpen31$8,709$281
Humulin R47$7,151$152
Glipizide119$1,694$14
Atorvastatin96$1,569$16
Metformin64$906$14
Metformin Hcl Er83$876$11
Ultra-Fine Mini Pen Needle14$506$36
Veo Insulin26$493$19
Pioglitazone17$493$29
Veo Insulin21$454$22
Ultra-Fine Nano Pen Needle14$318$23
Veo Insulin15$268$18
Lisinopril18$220$12

2021: 18 drugs

Part D drugs prescribed in 2021
Humulin N115$25,230$219
Jardiance29$22,575$778
Lantus15$13,529$902
Humulin R60$10,383$173
Humulin N Kwikpen35$9,435$270
Humalog12$2,770$231
Humulin 70-3013$2,110$162
Atorvastatin97$1,346$14
Glipizide95$1,268$13
Metformin Hcl Er76$762$10
Metformin52$736$14
Veo Insulin42$668$16
Glipizide Er11$656$60
Ultra-Fine Mini Pen Needle13$551$42
Pioglitazone13$332$26
Ultra-Fine Short Pen Needle11$330$30
Veo Insulin11$278$25
Lisinopril12$153$13

2020: 16 drugs

Part D drugs prescribed in 2020
Humulin N91$18,019$198
Humulin R43$8,772$204
Lantus12$6,692$558
Jardiance11$6,232$567
Humulin N Kwikpen31$5,141$166
Humalog Kwikpen U-10014$3,629$259
Atorvastatin133$2,216$17
Glipizide79$1,064$13
Veo Insulin45$712$16
Metformin Hcl Er69$682$10
Ultra-Fine Mini Pen Needle20$585$29
Metformin37$528$14
Lisinopril30$377$13
Simvastatin18$230$13
Losartan13$192$15
Lovastatin11$132$12

2019: 14 drugs

Part D drugs prescribed in 2019
Humulin N49$10,779$220
Lantus11$9,012$819
Humulin R24$3,994$166
Humulin 70-3015$2,798$187
Atorvastatin106$2,534$24
Veo Insulin30$620$21
Glipizide47$616$13
Metformin Hcl Er45$519$12
Metformin39$486$12
Rosuvastatin19$418$22
Simvastatin21$285$14
Lisinopril22$280$13
Losartan11$173$16
Lovastatin13$158$12

2018: 3 drugs

Part D drugs prescribed in 2018
Humulin N14$3,725$266
Humulin R11$1,662$151
Glipizide13$172$13

Professional record

NPI
1982066684
Licence
CA 75271California G75271: Cancelled
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 183500000X (183500000X)
Mailing address
1263 E Arques Ave, Sunnyvale, CA, 94085
NPI first listed
2016-03-22
NPI last updated
2021-11-22
NPI record certified
2021-11-22

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.